Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Jewell

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Nature|November 22, 2011
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxiaChristian M Metallo, Paulo A Gameiro, Eric L Bell, et al.
Scientific Reports|February 6, 2021
Lipid tethering of breast tumor cells reduces cell aggregation during mammosphere formationLekhana Bhandary, Patrick C Bailey, Katarina T Chang, et al.
Nature Communications|February 8, 2023
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantationJoshua M Gammon, Sean T Carey, Vikas Saxena, et al.
Breast Cancer Research : BCR|February 15, 2022
Microtubule disruption reduces metastasis more effectively than primary tumor growthKeyata N Thompson, Julia A Ju, Eleanor C Ory, et al.
Cancers|February 15, 2022
Microtentacle Formation in Ovarian CarcinomaJocelyn C Reader, Cong Fan, Eleanor Claire-Higgins Ory, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunitySenta M Kapnick, Emily A Gosselin, Shannon J Tsai, et al.
Nature Communications|December 2, 2024
Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signalingWenji Piao, Long Wu, Yanbao Xiong, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trialTuan Vu, Hacer Durmus, Michael Rivner, et al.
Science Immunology|January 19, 2024
CD4<sup>+</sup> T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responsesEmma G Bawden, Teagan Wagner, Jan Schröder, et al.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Nature|November 22, 2011
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxiaChristian M Metallo, Paulo A Gameiro, Eric L Bell, et al.
Scientific Reports|February 6, 2021
Lipid tethering of breast tumor cells reduces cell aggregation during mammosphere formationLekhana Bhandary, Patrick C Bailey, Katarina T Chang, et al.
Nature Communications|February 8, 2023
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantationJoshua M Gammon, Sean T Carey, Vikas Saxena, et al.
Breast Cancer Research : BCR|February 15, 2022
Microtubule disruption reduces metastasis more effectively than primary tumor growthKeyata N Thompson, Julia A Ju, Eleanor C Ory, et al.
Cancers|February 15, 2022
Microtentacle Formation in Ovarian CarcinomaJocelyn C Reader, Cong Fan, Eleanor Claire-Higgins Ory, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunitySenta M Kapnick, Emily A Gosselin, Shannon J Tsai, et al.
Nature Communications|December 2, 2024
Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signalingWenji Piao, Long Wu, Yanbao Xiong, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trialTuan Vu, Hacer Durmus, Michael Rivner, et al.
Science Immunology|January 19, 2024
CD4<sup>+</sup> T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responsesEmma G Bawden, Teagan Wagner, Jan Schröder, et al.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Pageof 14